GlassScriptPhysician profile
Jonathan M Feddock
NPI 1164685012
$1,500.51
in general payments reported to CMS, 2019-2025
9 companies · $27.75 in 2025
The $27.75 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,261 · 2023: $186 · 2024: $25.48 · 2025: $27.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,036.68 | 2019 | |
| Merck Sharp & Dohme LLC | $114.05 | 2019 | |
| Galvanize Therapeutics, INC | $113.12 | 2023 | Aliya System |
| Regeneron Healthcare Solutions, INC. | $110.49 | 2019 | |
| Isoray, INC | $72.94 | 2023 | Brachytherapy Source |
| Cumberland Pharmaceuticals, INC. | $25.48 | 2024 | Sancuso |
| Pfizer INC. | $14.20 | 2025 | |
| Novartis Pharmaceuticals Corporation | $13.55 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Feddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.